About Gaëlle
Gaëlle MERLIER is co-head of the Life Sciences Department.Gaëlle’s expertise spans advisory work on regulatory and contractual matters as well as the management of complex, serial litigation in commercial matters and health product liability. She also assists her clients during criminal investigations and in their dealings with the health authorities (particularly in the context of ANSM, DGCCRF, DDPP inspections, etc.). Furthermore, Gaëlle advises her clients on mergers-acquisitions and investments in the health sector (pharmaceutical companies, medical device manufacturers, clinical laboratories and other regulated health professions). Finally, she contributes to the launch of compliance programmes (anti-gift legislation, Sapin 2 Act, lobbying, etc.).Gaëlle MERLIER graduated from Paris 1 – Panthéon Sorbonne University, where she gained a postgraduate qualification in European Law then a Master of Laws in Health and Food Safety.After taking the oath in 2009, she first joined the law firm Hogan Lovells then the Paris office of Clifford Chance in 2011, where she was Counsel for Healthcare & Life Sciences, before moving to DELSOL Avocats in January 2022.Gaëlle MERLIER has been named a Rising Star in Health and Life Sciences by Legal 500 several times.She was elected by her peers as one of the Lawyers of the Year 2023 in « Biotechnology and Life Sciences Practice » by Best Lawyers (in partnership with Les Echos).Gaëlle has led the :Health Product Litigation Seminar within the two-year master’s degrees in « Health, Food and Environmental Safety Law » and « Medical Risks » at Paris 1 – Panthéon Sorbonne since 2011,« Obligations in corruption prevention (Sapin 2 Act) » lectures as part of the two-year « Business Law Applied to the Healthcare Industry » master’s degree at Saint-Etienne University since 2019.
Gaëlle MERLIER is co-head of the Life Sciences Department.Gaëlle’s expertise spans advisory work on regulatory and contractual matters as well as the management of complex, serial litigation in commercial matters and health product liability. She also assists her clients during criminal investigations and in their dealings with the health authorities (particularly in the context of ANSM, DGCCRF, DDPP inspections, etc.). Furthermore, Gaëlle advises her clients on mergers-acquisitions and investments in the health sector (pharmaceutical companies, medical device manufacturers, clinical laboratories and other regulated health professions). Finally, she contributes to the launch of compliance programmes (anti-gift legislation, Sapin 2 Act, lobbying, etc.).Gaëlle MERLIER graduated from Paris 1 – Panthéon Sorbonne University, where she gained a postgraduate qualification in European Law then a Master of Laws in Health and Food Safety.After taking the oath in 2009, she first joined the law firm Hogan Lovells then the Paris office of Clifford Chance in 2011, where she was Counsel for Healthcare & Life Sciences, before moving to DELSOL Avocats in January 2022.Gaëlle MERLIER has been named a Rising Star in Health and Life Sciences by Legal 500 several times.She was elected by her peers as one of the Lawyers of the Year 2023 in « Biotechnology and Life Sciences Practice » by Best Lawyers (in partnership with Les Echos).Gaëlle has led the :Health Product Litigation Seminar within the two-year master’s degrees in « Health, Food and Environmental Safety Law » and « Medical Risks » at Paris 1 – Panthéon Sorbonne since 2011,« Obligations in corruption prevention (Sapin 2 Act) » lectures as part of the two-year « Business Law Applied to the Healthcare Industry » master’s degree at Saint-Etienne University since 2019.
Gaëlle MERLIER is co-head of the Life Sciences Department.
Gaëlle’s expertise spans advisory work on regulatory and contractual matters as well as the management of complex, serial litigation in commercial matters and health product liability. She also assists her clients during criminal investigations and in their dealings with the health authorities (particularly in the context of ANSM, DGCCRF, DDPP inspections, etc.). Furthermore, Gaëlle advises her clients on mergers-acquisitions and investments in the health sector (pharmaceutical companies, medical device manufacturers, clinical laboratories and other regulated health professions). Finally, she contributes to the launch of compliance programmes (anti-gift legislation, Sapin 2 Act, lobbying, etc.).
Gaëlle MERLIER graduated from Paris 1 – Panthéon Sorbonne University, where she gained a postgraduate qualification in European Law then a Master of Laws in Health and Food Safety.
After taking the oath in 2009, she first joined the law firm Hogan Lovells then the Paris office of Clifford Chance in 2011, where she was Counsel for Healthcare & Life Sciences, before moving to DELSOL Avocats in January 2022.
Gaëlle MERLIER has been named a Rising Star in Health and Life Sciences by Legal 500 several times.
She was elected by her peers as one of the Lawyers of the Year 2023 in « Biotechnology and Life Sciences Practice » by Best Lawyers (in partnership with Les Echos).
Gaëlle has led the :
Gaëlle MERLIER is co-head of the Life Sciences Department.Gaëlle’s expertise spans advisory work on regulatory and contractual matters as well as the management of complex, serial litigation in commercial matters and health product liability. She also assists her clients during criminal investigations and in their dealings with the health authorities (particularly in the context of ANSM, DGCCRF, DDPP inspections, etc.). Furthermore, Gaëlle advises her clients on mergers-acquisitions and investments in the health sector (pharmaceutical companies, medical device manufacturers, clinical laboratories and other regulated health professions). Finally, she contributes to the launch of compliance programmes (anti-gift legislation, Sapin 2 Act, lobbying, etc.).Gaëlle MERLIER graduated from Paris 1 – Panthéon Sorbonne University, where she gained a postgraduate qualification in European Law then a Master of Laws in Health and Food Safety.After taking the oath in 2009, she first joined the law firm Hogan Lovells then the Paris office of Clifford Chance in 2011, where she was Counsel for Healthcare & Life Sciences, before moving to DELSOL Avocats in January 2022.Gaëlle MERLIER has been named a Rising Star in Health and Life Sciences by Legal 500 several times.She was elected by her peers as one of the Lawyers of the Year 2023 in « Biotechnology and Life Sciences Practice » by Best Lawyers (in partnership with Les Echos).Gaëlle has led the :Health Product Litigation Seminar within the two-year master’s degrees in « Health, Food and Environmental Safety Law » and « Medical Risks » at Paris 1 – Panthéon Sorbonne since 2011,« Obligations in corruption prevention (Sapin 2 Act) » lectures as part of the two-year « Business Law Applied to the Healthcare Industry » master’s degree at Saint-Etienne University since 2019.
Gaëlle MERLIER is co-head of the Life Sciences Department.
Gaëlle’s expertise spans advisory work on regulatory and contractual matters as well as the management of complex, serial litigation in commercial matters and health product liability. She also assists her clients during criminal investigations and in their dealings with the health authorities (particularly in the context of ANSM, DGCCRF, DDPP inspections, etc.). Furthermore, Gaëlle advises her clients on mergers-acquisitions and investments in the health sector (pharmaceutical companies, medical device manufacturers, clinical laboratories and other regulated health professions). Finally, she contributes to the launch of compliance programmes (anti-gift legislation, Sapin 2 Act, lobbying, etc.).
Gaëlle MERLIER graduated from Paris 1 – Panthéon Sorbonne University, where she gained a postgraduate qualification in European Law then a Master of Laws in Health and Food Safety.
After taking the oath in 2009, she first joined the law firm Hogan Lovells then the Paris office of Clifford Chance in 2011, where she was Counsel for Healthcare & Life Sciences, before moving to DELSOL Avocats in January 2022.
Gaëlle MERLIER has been named a Rising Star in Health and Life Sciences by Legal 500 several times.
She was elected by her peers as one of the Lawyers of the Year 2023 in « Biotechnology and Life Sciences Practice » by Best Lawyers (in partnership with Les Echos).
Gaëlle has led the :
